| ASSET | MONTH | % RETURN |
|---|---|---|
Oklo (OKLO) | January 2025 | 96% |
GRAIL, LLC (GRAL) | January 2025 | 69.92% |
Hims Hers Health (HIMS) | January 2025 | 51.42% |
Sellas Life Sciences (SLS) | January 2025 | 50% |
Planet Labs PBC (PL) | January 2025 | 49.14% |
Redwire (RDW) | January 2025 | 41.37% |
MP Materials (MP) | January 2025 | 38.55% |
Dana (DAN) | January 2025 | 38.49% |
Clover Health Investments (CLOV) | January 2025 | 38.49% |
Grupo Aval (AVAL) | January 2025 | 37.73% |
Brinker International (EAT) | January 2025 | 36.33% |
Acm Research (ACMR) | January 2025 | 35.11% |
Option Care Health (OPCH) | January 2025 | 32.7% |
Progyny (PGNY) | January 2025 | 32.25% |
Xpeng (XPEV) | January 2025 | 31.55% |
Life Time (LTH) | January 2025 | 30.88% |
AtriCure (ATRC) | January 2025 | 29.66% |
Stride (LRN) | January 2025 | 29.1% |
Super (SGHC) | January 2025 | 29.03% |
Nuscale Power (SMR) | January 2025 | 28.38% |
Brighthouse Financial (BHF) | January 2025 | 27.87% |
Allied Gold (AAUC) | January 2025 | 27.35% |
Gitlab (GTLB) | January 2025 | 27.29% |
Adaptive Biotechnologies (ADPT) | January 2025 | 27.26% |
Schrodinger (SDGR) | January 2025 | 27.16% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.